Acute coronary findings at autopsy in heart failure patients with sudden death - Results from the Assessment of Treatment with Lisinopril and Survival (ATLAS) Trial

被引:245
作者
Uretsky, BF
Thygesen, K
Armstrong, PW
Cleland, JG
Horowitz, JD
Massie, BM
Packer, M
Poole-Wilson, PA
Ryden, L
机构
[1] Aarhus Univ Hosp, Aarhus, Denmark
[2] Univ Texas, Med Branch, Galveston, TX 77550 USA
[3] Univ Hull, Hull HU6 7RX, N Humberside, England
[4] Univ Alberta, Edmonton, AB T6G 2M7, Canada
[5] Univ Adelaide, Adelaide, SA 5005, Australia
[6] Univ Calif San Francisco, San Francisco, CA 94143 USA
[7] Columbia Univ, New York, NY 10027 USA
[8] Univ London Imperial Coll Sci Technol & Med, Sch Med, London SW7 2AZ, England
[9] Karolinska Inst, Stockholm, Sweden
关键词
death; sudden; heart failure; ischemia;
D O I
10.1161/01.CIR.102.6.611
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Sudden unexpected death frequently occurs in chronic heart failure. The importance of acute coronary events in triggering sudden death (SD) is unclear. Methods and Results-We evaluated at autopsy the prevalence of acute coronary findings (coronary thrombus, ruptured plaque, or myocardial infarction [MI]) and their relation to SD. Autopsy results in 171 patients in the randomized ATLAS trial were reviewed, The prevalence of acute coronary findings was 33%: in 54% of patients with significant coronary artery disease (CAD) who died suddenly, 32% who died of myocardial failure, but in non-CAD patients, they were present in only 5% and 10% respectively. The percentage of patients classified as dying of MI was 28% in the autopsy group versus 4% in the nonautopsied group (P<0.0001). Of the autopsied group with acute MI, 97% (31 of 32 patients) with SD and 40% (6 of 15 patients) with myocardial failure did not have the MI diagnosed during life, When undiagnosed MI was classified as "sudden unexpected" or "myocardial failure:' from clinical information only, the distribution of death causes was similar in the autopsy and nonautopsied groups. Conclusions-Acute coronary findings are frequent and usually not clinically diagnosed in heart failure patients with CAD, particularly in those dying suddenly, suggesting the importance of acute coronary events as a trigger for SD in this setting.
引用
收藏
页码:611 / 616
页数:6
相关论文
共 22 条
  • [1] Antiplatelet agents and survival: A cohort analysis from the studies of left ventricular dysfunction (SOLVD) trial
    Al-Khadra, AS
    Salem, DN
    Rand, WM
    Udelson, JE
    Smith, JJ
    Konstam, MA
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 31 (02) : 419 - 425
  • [2] BABA N, 1975, CIRCULATION S3, V53, P53
  • [3] BALL SG, 1993, LANCET, V342, P821
  • [4] BASHE WJ, 1975, CIRCULATION S3, V53, P63
  • [5] Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT
    Cairns, JA
    Connolly, SJ
    Roberts, R
    Gent, M
    [J]. LANCET, 1997, 349 (9053) : 675 - 682
  • [6] EFFECT OF VASODILATOR THERAPY ON MORTALITY IN CHRONIC CONGESTIVE-HEART-FAILURE - RESULTS OF A VETERANS-ADMINISTRATION COOPERATIVE STUDY
    COHN, JN
    ARCHIBALD, DG
    ZIESCHE, S
    FRANCIOSA, JA
    HARSTON, WE
    TRISTANI, FE
    DUNKMAN, WB
    JACOBS, W
    FRANCIS, GS
    FLOHR, KH
    GOLDMAN, S
    COBB, FR
    SHAH, PM
    SAUNDERS, R
    FLETCHER, RD
    LOEB, HS
    HUGHES, VC
    BAKER, B
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1986, 314 (24) : 1547 - 1552
  • [7] A COMPARISON OF ENALAPRIL WITH HYDRALAZINE ISOSORBIDE DINITRATE IN THE TREATMENT OF CHRONIC CONGESTIVE-HEART-FAILURE
    COHN, JN
    JOHNSON, G
    ZIESCHE, S
    COBB, F
    FRANCIS, G
    TRISTANI, F
    SMITH, R
    DUNKMAN, WB
    LOEB, H
    WONG, ML
    BHAT, G
    GOLDMAN, S
    FLETCHER, RD
    DOHERTY, J
    HUGHES, CV
    CARSON, P
    CINTRON, G
    SHABETAI, R
    HAAKENSON, C
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (05) : 303 - 310
  • [8] DAVIES MJ, 1992, CIRCULATION, V85, P19
  • [9] RANDOMIZED TRIAL OF LOW-DOSE AMIODARONE IN SEVERE CONGESTIVE-HEART-FAILURE
    DOVAL, HC
    NUL, DR
    GRANCELLI, HO
    PERRONE, SV
    BORTMAN, GR
    CURIEL, R
    [J]. LANCET, 1994, 344 (8921) : 493 - 498
  • [10] MORTALITY AND MORBIDITY IN PATIENTS RECEIVING ENCAINIDE, FLECAINIDE, OR PLACEBO - THE CARDIAC-ARRHYTHMIA SUPPRESSION TRIAL
    ECHT, DS
    LIEBSON, PR
    MITCHELL, LB
    PETERS, RW
    OBIASMANNO, D
    BARKER, AH
    ARENSBERG, D
    BAKER, A
    FRIEDMAN, L
    GREENE, HL
    HUTHER, ML
    RICHARDSON, DW
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (12) : 781 - 788